SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. I: In Vitro StudiesEric Bignon, Gérard Le Fur, M. Cottineau et al.|Journal of Pharmacology and Experimental Therapeutics|1999Cited by 36
Experimental Studies on Guanosine 3’,5’-Cyclic Monophosphate Levels and Airway Responsiveness of the Novel Phosphodiesterase Type 5 InhibitorZoltan Kapuia, Marc Pascal, Paul Schaeffer et al.|Arzneimittelforschung|2011Cited by 16